Estreva oral (estradiol oral) / Theramex - LARVOL DELTA

Effect of intrauterine ozone therapy on Asherman syndrome, an experimental rat model. (PubMed, Eur J Obstet Gynecol Reprod Biol) - "Ozone had a positive effect on the treatment of Asherman syndrome and has a significant impact on achieving pregnancy."

Journal • Preclinical

Binge Eating & Birth Control (clinicaltrials.gov) - P2 | N=8 | Terminated | Sponsor: University of North Carolina, Chapel Hill | Active, not recruiting ➔ Terminated; Halted prematurely due to COVID-19-related enrollment challenges.

Trial termination • Binge Eating Disorder • Bulimia • CNS Disorders • Long-acting Reversible Contraceptives

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy (clinicaltrials.gov) - P=N/A; N=1578; Completed; Sponsor: National Institute of Allergy and Infectious Diseases (NIAID); Phase classification: P4 ➔ P=N/A

Phase classification • Human Immunodeficiency Virus • Infectious Disease

Binge Eating & Birth Control (clinicaltrials.gov) - P2; N=15; Recruiting; Sponsor: University of North Carolina, Chapel Hill; Trial completion date: Jul 2021 ➔ Jul 2022; Trial primary completion date: Jul 2021 ➔ Jul 2022

Trial completion date • Trial primary completion date • Binge Eating Disorder • Bulimia • CNS Disorders • Long-acting Reversible Contraceptives • MRI

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy (clinicaltrials.gov) - P4; N=1578; Completed; Sponsor: National Institute of Allergy and Infectious Diseases (NIAID); Active, not recruiting ➔ Completed

Trial completion • Human Immunodeficiency Virus • Infectious Disease

Binge Eating & Birth Control (clinicaltrials.gov) - P2; N=15; Recruiting; Sponsor: University of North Carolina, Chapel Hill; Not yet recruiting ➔ Recruiting; Initiation date: Apr 2020 ➔ Sep 2020

Enrollment open • Trial initiation date • Binge Eating Disorder • Bulimia • CNS Disorders • Long-acting Reversible Contraceptives • Psychiatry

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy (clinicaltrials.gov) - P4; N=1786; Recruiting; Sponsor: National Institute of Allergy and Infectious Diseases (NIAID); Trial primary completion date: Jun 2019 ➔ Mar 2018

Trial primary completion date • Biosimilar • Gene Therapies • Human Immunodeficiency Virus • Immunology

Binge Eating & Birth Control (clinicaltrials.gov) - P2; N=15; Not yet recruiting; Sponsor: University of North Carolina, Chapel Hill

New P2 trial • MRI

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy (clinicaltrials.gov) - P4; N=1786; Active, not recruiting; Sponsor: National Institute of Allergy and Infectious Diseases (NIAID); Recruiting ➔ Active, not recruiting

Enrollment closed

Changes in Musculoskeletal System and Metabolism in Osteoporotic Rats Treated With Urocortin. (PubMed, Front Endocrinol (Lausanne)) - "Urocortin raises serum cholesterol and triglyceride levels. Bone tissue was not affected by UCN."

Journal • Preclinical

A novel and simple method to schedule GnRH antagonist cycles with a short course of oral estradiol in the early follicular phase (ESHRE 2019) - "FES does not require advance planning, involves shorter use of estradiol/oral contraceptive tablets and can be advantageous to scheduling with luteal estradiol/oral contraceptive administration. If further studies provide reassurance for pregnancy rates, FES can be the method of choice for cycle scheduling."

A novel and simple method to schedule GnRH antagonist cycles with a short course of oral estradiol in the early follicular phase (ESHRE 2019) - "FES does not require advance planning, involves shorter use of estradiol/oral contraceptive tablets and can be advantageous to scheduling with luteal estradiol/oral contraceptive administration. If further studies provide reassurance for pregnancy rates, FES can be the method of choice for cycle scheduling."

A novel and simple method to schedule GnRH antagonist cycles with a short course of oral estradiol in the early follicular phase (ESHRE 2019) - "FES does not require advance planning, involves shorter use of estradiol/oral contraceptive tablets and can be advantageous to scheduling with luteal estradiol/oral contraceptive administration. If further studies provide reassurance for pregnancy rates, FES can be the method of choice for cycle scheduling."

A novel and simple method to schedule GnRH antagonist cycles with a short course of oral estradiol in the early follicular phase (ESHRE 2019) - "FES does not require advance planning, involves shorter use of estradiol/oral contraceptive tablets and can be advantageous to scheduling with luteal estradiol/oral contraceptive administration. If further studies provide reassurance for pregnancy rates, FES can be the method of choice for cycle scheduling."

Effects of oral contraceptives on ovulation induction in in vitro fertilization patients with premature ovarian insufficiency. (PubMed, Climacteric) - "Oral contraception may be an effective method to induce ovulation for some patients with premature ovarian insufficiency."

Journal

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy (clinicaltrials.gov) - P4; N=1786; Recruiting; Sponsor: National Institute of Allergy and Infectious Diseases (NIAID); Trial completion date: Sep 2019 ➔ Sep 2020; Trial primary completion date: Jun 2019 ➔ Sep 2020

Trial completion date • Trial primary completion date

Sexual dimorphism in the physiological response of the Apoe-/-atherosclerosis model to sleep fragmentation. (AAI 2019) - "Altogether, SF alters the immune response in male atherosclerotic Apoe-/-mice resulting in early death. Our data suggests that the hormonal landscape in female Apoe-/-mice protects against SF-induced premature death via estrogen-dependent mechanisms"